Guideline Updates Prior AuthorizationAnthem Blue Cross and Blue Shield | CommercialJanuary 1, 2024

Expansion of Carelon Medical Benefits Management, Inc. programs effective April 1, 2024

As communicated in the October 2023 provider newsletter, effective April 1, 2024, Carelon Medical Benefits Management, Inc., a specialty health benefits company, will expand multiple Carelon Medical Benefits Management programs to perform medical necessity reviews for additional procedures for Anthem members, as further outlined below. Carelon Medical Benefits Management works with leading insurers to improve healthcare quality and manage costs for today’s most complex and prevalent tests and treatments, helping to promote care that is appropriate, safe, and affordable.

The expansion will require clinical appropriateness review for additional procedures related to the Carelon Medical Benefits Management expanded cardiology, genetic testing, radiology, musculoskeletal, surgical and radiation oncology programs. The Clinical Guidelines and Medical Policies that have been adopted by Anthem to be used for medical necessity review are in the table below. Carelon Medical Benefits Management will begin accepting prior authorization requests on March 18, 2024, for dates of service April 1, 2024, and after.

Members included in the new program

All fully insured, self-funded (ASO), HealthLink, and National members currently participating in the Carelon Medical Benefits Management programs listed below are included. For self-funded (ASO) groups that currently do not participate in the Carelon Medical Benefits Management programs, the program will be offered to self-funded accounts (ASO) to add to their members’ benefit package as of April 1, 2024. A separate notice will be published for Medicare Advantage, Medicare, and MA GRS.

Members of the following products are excluded: Medicaid, Medicare supplement, Federal Employee Program® (FEP®).

Pre-service review requirements

To determine if prior authorization is needed for a member on or after April 1, 2024, contact the Provider Services phone number on the back of the member’s ID card for benefit information.  Providers using the Interactive Care Reviewer (ICR) tool on the Availity Essentials website to pre-certify an outpatient procedure will receive a message referring the provider to Carelon Medical Benefits Management (Note: ICR cannot accept prior authorization requests for services administered by Carelon Medical Benefits Management).

For procedures that are scheduled to begin on or after April 1, 2024, all providers with the following programs must contact Carelon Medical Benefits Management to obtain pre-service review for the services including but not limited to the following non-emergency modalities. Please refer to the Clinical Guidelines on the microsite resource pages for complete code lists.

Note: The procedure list has been updated since the November notification. All codes will only be reviewed for medical necessity for the requested service and not for site of care at this time.

Program

Services

Clinical Guidelines

Expanded cardiology

  • Treatment of varicose veins
  • Artery stent placement w/wo angioplasty
  • Embolization procedure
  • Dialysis circuit procedure
  • EPS studies
  • Cardiac ablation
  • Cardiac monitor device
  • Cardiac contractility modulation
  • Wearable cardioverter defibrillators
  • Wireless CRT for left ventricular pacing
  • Venous angioplasty w/wo stent placement
  • Vein embolization treatment for pelvic congestion syndrome and varicocele
  • PFO closure devices
  • CG-MED-64
  • CG-MED-74
  • CG-SURG-28
  • CG-SURG-55
  • CG-SURG-76
  • CG-SURG-83
  • CG-SURG-93
  • CG-SURG-106
  • MED.00055
  • RAD.00059
  • SURG.00032
  • SURG.00037
  • SURG.00062
  • SURG.00152
  • SURG.00153
  • THER-RAD.00012

Genetic testing

  • Topographic genotyping
  • Chromosomal microarray analysis
  • Gene expression profiling
  • Gene mutation testing
  • Gene sequencing
  • Panel and other multi-gene test for polymorphisms
  • Genetic test for inherited diseases
  • Molecular marker evaluation of thyroid nodules
  • Hybrid personalized molecular residual disease test for cancer
  • BRCA gene test
  • Cell-free DNA test to aid in monitoring of kidney transplant rejection
  • Laboratory test to aid in dx of heart transplant rejection
  • Carrier Screening in the Prenatal Setting and Preimplantation Genetic Testing
  • Cell-free DNA Testing (Liquid Biopsy) for the Management of Cancer
  • Chromosomal Microarray Analysis
  • Genetic Testing for Inherited Conditions
  • Hereditary Cancer Testing
  • LAB.00025
  • LAB.00050
  • Pharmacogenomic Testing
  • Polygenic Risk Scores
  • Somatic Tumor Testing
  • Whole Exome Sequencing and Whole Genome Sequencing

Radiology

  • Radiostereometric analysis
  • Quantitative ultrasound for tissue characterization
  • Myocardial sympathetic innervation and imaging w/wo spect.
  • Lumbar discography
  • CG-SURG-29
  • RAD.00064
  • RAD.00065
  • RAD.00067

Musculoskeletal

  • Extraosseous subtalar joint imp and arthroereisis
  • Genicular Nerve block and ablation — CHR knee pain
  • Percutaneous and endo spinal surgery
  • Implanted devices for spinal stenosis
  • Percutaneous vert disc and endplate procedures
  • Cryoablation for podiatric conditions
  • SURG.00052
  • SURG.00071
  • SURG.00092
  • SURG.00100
  • SURG.00104
  • SURG.00142

Surgical

  • Wireless capsule endoscopy
  • Bariatric surgery
  • Paraoesophageal hernia repair
  • Ablation proc. — treatment of Barrett’s esophagus
  • Transendoscopic therapy for GE reflux/dysphagia/gastroparesis
  • Lower esophageal sphincter augmentation devices
  • CG-SURG-83
  • CG-SURG-92
  • CG-SURG-101
  • MED.00090
  • SURG.00047
  • SURG.00131

Radiation oncology

  • Hyperthermia for cancer therapy
  • CG-MED-72

Providers should continue to submit pre-service review requests to Carelon Medical Benefits Management using the convenient online service via the Carelon Medical Benefits Management ProviderPortalSM. ProviderPortal is available 24 hours a day, seven days a week, processing requests in real-time using Clinical Criteria. Go to providers.carelonmedicalbenefitsmanagement.com to register.

For more information

For resources to help your practice get started with the radiology, expanded cardiology, genetic testing, musculoskeletal, surgical, and radiation oncology programs, go to:

These websites include helpful information and tools such as order entry checklists, Clinical Guidelines, and FAQs. You can also call your local provider relationship management representative if you have any questions.

We value your participation in our network and look forward to working with you to help improve the health of our members.

Carelon Medical Benefits Management, Inc. is an independent company providing utilization management services on behalf of the health plan.

Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of Virginia, Inc. Anthem Blue Cross and Blue Shield, and its affiliate HealthKeepers, Inc., serving all of Virginia except for the City of Fairfax, the Town of Vienna, and the area east of State Route 123, are independent licensees of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CM-047241-23

PUBLICATIONS: January 2024 Provider Newsletter